Molecular and genetic mechanisms of osteoporosis: implication for treatment
- PMID: 14682495
- DOI: 10.2174/1566524033479375
Molecular and genetic mechanisms of osteoporosis: implication for treatment
Abstract
Osteoporosis is a leading public health problem in our rapidly growing, aging population. It is characterized by reduced bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture risk. Osteoporosis is a complex multifactorial disease, determined by genetic and environmental factors as well as their interactions. A large number of molecular, genetic and environmental factors underlying osteoporosis have been identified in past decades. In this article, we review 1) the molecular mechanisms of several principal systemic and local factors regulating bone metabolism; and 2) the current status of genetic studies searching for genes underlying osteoporosis. Further, we attempt to integrate knowledge from those two fields, and their potential implications for osteoporosis treatment.
Similar articles
-
Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms.J Steroid Biochem Mol Biol. 2002 May;81(1):1-24. doi: 10.1016/s0960-0760(02)00043-2. J Steroid Biochem Mol Biol. 2002. PMID: 12127038 Review.
-
Role of genetic factors in the pathogenesis of osteoporosis.J Endocrinol. 2000 Aug;166(2):235-45. doi: 10.1677/joe.0.1660235. J Endocrinol. 2000. PMID: 10927613 Review.
-
Evaluation of therapeutic efficacy in osteoporosis.Osteoporos Int. 1995 Mar;5(2):75-8. doi: 10.1007/BF01623307. Osteoporos Int. 1995. PMID: 7599452 Review.
-
Recent progress in understanding the genetic susceptibility to osteoporosis.Genet Epidemiol. 1999;16(4):356-67. doi: 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I. Genet Epidemiol. 1999. PMID: 10207717 Review.
-
[Osteoporosis--pathophysiology and laboratory diagnostic methods].Przegl Lek. 2010;67(7):502-11. Przegl Lek. 2010. PMID: 21387765 Review. Polish.
Cited by
-
Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.J Bone Miner Metab. 2006;24(1):65-71. doi: 10.1007/s00774-005-0648-x. J Bone Miner Metab. 2006. PMID: 16369901
-
Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?Drugs. 2007;67(16):2311-21. doi: 10.2165/00003495-200767160-00002. Drugs. 2007. PMID: 17983253 Review.
-
Correlation of transmenopausal bone mass in healthy white women: a long-term longitudinal study.Osteoporos Int. 2006 Oct;17(10):1501-5. doi: 10.1007/s00198-006-0150-x. Epub 2006 Jul 29. Osteoporos Int. 2006. PMID: 16896513
-
The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort.Osteoporos Int. 2010 Mar;21(3):467-77. doi: 10.1007/s00198-009-0981-3. Epub 2009 Jun 9. Osteoporos Int. 2010. PMID: 19506792 Review.
-
Molecular genetic studies of gene identification for osteoporosis: a 2004 update.J Bone Miner Res. 2006 Oct;21(10):1511-35. doi: 10.1359/jbmr.051002. J Bone Miner Res. 2006. PMID: 16995806 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous